| Literature DB >> 24959107 |
Shruti Gupta1, Tanuja Kushwah1, Shweta Yadav1.
Abstract
Earthworms can 'biotransform' or 'biodegrade' chemical contaminants, rendering them harmless in their bodies, and can bioaccumulate them in their tissues. They 'absorb' the dissolved chemicals through their moist 'body wall' due to the interstitial water and also ingest by 'mouth' while soil passes through the gut. Since the advent of the nanotechnology era, the environmental sink has been continuously receiving engineered nanomaterials as well as their derivatives. Our current understanding of the potential impact of nanomaterials and their natural scavenger is limited. In the present investigation, we studied the cellular uptake of ZnO nanoparticles (NPs) by coelomocytes especially by chloragocytes of Eisenia fetida and their role as nanoscavenger. Results from exposure to 100- and 50-nm ZnO NPs indicate that coelomocytes of the earthworm E. fetida show no significant DNA damage at a dose lower than 3 mg/l and have the potential ability to uptake ZnO NPs from the soil ecosystem and transform them into microparticles.Entities:
Keywords: Biotransformation; Chloragocytes; Coelomocytes; Eisenia fetida; Internalization; Nanoscavenger
Year: 2014 PMID: 24959107 PMCID: PMC4060845 DOI: 10.1186/1556-276X-9-259
Source DB: PubMed Journal: Nanoscale Res Lett ISSN: 1556-276X Impact factor: 4.703
Figure 1DNA damage of coelomocytes (A) in the control and (B) after exposure to 100-nm NPs (3 mg/l).
Figure 2Viability of coelomocytes after exposure to ZnO NPs (100 nm) at different intervals.
Figure 3Viability of coelomocytes after exposure to ZnO NPs (50 nm) at different intervals.
Figure 4Total viability of coelomocytes after exposure to ZnO NPs: (A) 100 nm and (B) 50 nm.
DNA damage after exposure to ZnO NPs on coelomocytes of at different intervals
| 1 | 0.0 | Nil | 0 | 51 | 52 | 103 | 72.62 | 27.37 | 14.23 | 10.27 |
| 2 | 1.0 | 100 | 12 | 50 | 51 | 104 | 72.62 | 26.43 | 14.12 | 10.17 |
| 3 | 1.0 | 100 | 24 | 51 | 52 | 103 | 72.61 | 27.32 | 14.13 | 10.17 |
| 4 | 1.0 | 100 | 36 | 52 | 53 | 104 | 72.51 | 27.03 | 14.23 | 10.23 |
| 5 | 1.0 | 100 | 48 | 51 | 52 | 104 | 72.61 | 27.31 | 14.34 | 11.23 |
| 6 | 1.0 | 50 | 12 | 50 | 51 | 104 | 72.62 | 26.43 | 14.12 | 10.17 |
| 7 | 1.0 | 50 | 24 | 51 | 52 | 102 | 71.12 | 27.32 | 14.13 | 10.17 |
| 8 | 1.0 | 50 | 36 | 52 | 53 | 104 | 72.51 | 27.03 | 14.23 | 10.23 |
| 9 | 1.0 | 50 | 48 | 51 | 52 | 104 | 72.61 | 27.31 | 14.34 | 11.23 |
| 10 | 3.0 | 100 | 12 | 77 | 56 | 133 | 82.5 | 17.49 | 9.79 | 7.79 |
| 11 | 3.0 | 100 | 24 | 111 | 144 | 255 | 85.39 | 18.62 | 21.03 | 12.82 |
| 12 | 3.0 | 100 | 36 | 105 | 176 | 281 | 73.24 | 26.75 | 57.04 | 25.17 |
| 13 | 3.0 | 100 | 48 | 109 | 116 | 225 | 60.67 | 39.32 | 45.6 | 33.83 |
| 14 | 3.0 | 50 | 12 | 83 | 42 | 125 | 89.12 | 10.87 | 4.56 | 4.66 |
| 15 | 3.0 | 50 | 24 | 71 | 62 | 133 | 81.98 | 18.01 | 11.17 | 8.18 |
| 16 | 3.0 | 50 | 36 | 71 | 74 | 245 | 91.25 | 18.74 | 6.47 | 8.23 |
| 17 | 3.0 | 50 | 48 | 75 | 121 | 296 | 57.59 | 42.41 | 51.3 | 27.63 |
| 18 | 5.0 | 100 | 12 | 83 | 32 | 115 | 90.96 | 9.03 | 2.89 | 4.22 |
| 19 | 5.0 | 100 | 24 | 77 | 52 | 129 | 70.83 | 15.16 | 15.16 | 12.64 |
| 20 | 5.0 | 100 | 36 | 129 | 74 | 203 | 83.72 | 16.27 | 12.04 | 14.34 |
| 21 | 5.0 | 100 | 48 | 105 | 176 | 281 | 73.24 | 26.75 | 47.09 | 25.17 |
| 22 | 5.0 | 50 | 12 | 113 | 87 | 200 | 85.8 | 14.19 | 12.34 | 10.42 |
| 23 | 5.0 | 50 | 24 | 115 | 132 | 247 | 80.92 | 19.07 | 25.18 | 16.43 |
| 24 | 5.0 | 50 | 36 | 85 | 155 | 240 | 65.69 | 34.32 | 53.17 | 27.82 |
| 25 | 5.0 | 50 | 48 | 65 | 135 | 242 | 35.69 | 64.31 | 86.8 | 41.53 |
Figure 5Comet assay of coelomocytes after exposure to 50-nm ZnO NPs (3 mg/l) at different intervals.
Figure 6Comet assay of coelomocytes after exposure to 50-nm ZnO NPs (5 mg/l) at different intervals.
Figure 7Comet assay of coelomocytes after exposure to 100-nm ZnO NPs (5 mg/l) at different intervals.
Figure 8Comet assay of coelomocytes after exposure to 100-nm ZnO NPs (3 mg/l) at different intervals.